small molecule glp 1 A small-molecule oral agonist of the human glucagon-like peptide-1 receptor Oral Small-Molecule GLP-1 Receptor Agonists:
Description
Llorente G.

Combined therapy with two classes of antidiabetic agents, namely, dipeptidyl peptidase 4 inhibitors and sodium-glucose co-transporter-2 inhibitors, target several pathophysiological pathways

for severe obesity and Type 2 diabetes, the entry of low-cost generic versions has led to widespread misuse via online pharmacies and wellness clinics.

Expert news, articles, R&D, interviews, and market insights for feed professionals.

What to expect while on GLP-1 treatment
